Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 262


HPV Testing With 16, 18, and 45 Genotyping Stratifies Cancer Risk for Women With Normal Cytology: Data From the Baseline Phase of the Onclarity Trial.

Stoler MH, Wright TC Jr, Parvu V, Yanson K, Eckert K, Kodsi S, Cooper C.

Am J Clin Pathol. 2019 Jan 14. doi: 10.1093/ajcp/aqy169. [Epub ahead of print]


Stratified risk of high-grade cervical disease using onclarity HPV extended genotyping in women, ≥25 years of age, with NILM cytology.

Stoler MH, Wright TC Jr, Parvu V, Yanson K, Cooper CK, Andrews J.

Gynecol Oncol. 2019 Jan 9. pii: S0090-8258(18)31538-5. doi: 10.1016/j.ygyno.2018.12.024. [Epub ahead of print]


Ex Vivo Assessment of Porcine Donation After Circulatory Death Lungs That Undergo Increasing Warm Ischemia Times.

Charles EJ, Hunter Mehaffey J, Huerter ME, Sharma AK, Stoler MH, Roeser ME, Walters DM, Tribble CG, Kron IL, Laubach VE.

Transplant Direct. 2018 Nov 12;4(12):e405. doi: 10.1097/TXD.0000000000000845. eCollection 2018 Dec.


Detection of Cervical Neoplasia by Human Papillomavirus Testing in an Atypical Squamous Cells-Undetermined Significance Population: Results of the Becton Dickinson Onclarity Trial.

Wright TC Jr, Stoler MH, Parvu V, Yanson K, Eckert K, Kodsi S, Cooper CK.

Am J Clin Pathol. 2019 Jan 1;151(1):53-62. doi: 10.1093/ajcp/aqy084.


Necrobiotic Pulmonary Nodules of Crohn's Disease in a Patient Receiving Vedolizumab.

Myc LA, Girton MR, Stoler MH, Davis EM.

Am J Respir Crit Care Med. 2019 Jan 1;199(1):e1-e2. doi: 10.1164/rccm.201806-1056IM. No abstract available.


PD-L1 and IDO expression in cervical and vulvar invasive and intraepithelial squamous neoplasias: implications for combination immunotherapy.

Chinn Z, Stoler MH, Mills AM.

Histopathology. 2019 Jan;74(2):256-268. doi: 10.1111/his.13723. Epub 2018 Oct 29.


Human Papillomavirus Genotypes From Vaginal and Vulvar Intraepithelial Neoplasia in Females 15-26 Years of Age.

Garland SM, Joura EA, Ault KA, Bosch FX, Brown DR, Castellsagué X, Ferenczy A, Ferris DG, Giuliano AR, Hernandez-Avila M, Huh WK, Iversen OE, Kjaer SK, Kurman RJ, Luna J, Monsonego J, Muñoz N, Paavonen J, Pitisuttihum P, Ronnett BM, Steben M, Stoler MH, Wheeler CM, Wiley DJ, Perez G, Saah AJ, Luxembourg A, Li S, DiNubile MJ, Wagner M, Velicer C.

Obstet Gynecol. 2018 Aug;132(2):261-270. doi: 10.1097/AOG.0000000000002736.


HPV RNA in situ hybridization can inform cervical cytology-histology correlation.

Coppock JD, Willis BC, Stoler MH, Mills AM.

Cancer Cytopathol. 2018 Aug;126(8):533-540. doi: 10.1002/cncy.22027. Epub 2018 Jul 5.


Routine Use of Adjunctive p16 Immunohistochemistry Improves Diagnostic Agreement of Cervical Biopsy Interpretation: Results From the CERTAIN Study.

Stoler MH, Wright TC Jr, Ferenczy A, Ranger-Moore J, Fang Q, Kapadia M, Ridder R.

Am J Surg Pathol. 2018 Aug;42(8):1001-1009. doi: 10.1097/PAS.0000000000001072.


The Onclarity Human Papillomavirus Trial: Design, methods, and baseline results.

Stoler MH, Wright TC Jr, Parvu V, Vaughan L, Yanson K, Eckert K, Karchmer T, Kodsi S, Cooper CK.

Gynecol Oncol. 2018 Jun;149(3):498-505. doi: 10.1016/j.ygyno.2018.04.007. Epub 2018 Apr 19.


Eosinophils promote inducible NOS-mediated lung allograft acceptance.

Onyema OO, Guo Y, Wang Q, Stoler MH, Lau C, Li K, Nazaroff CD, Wang X, Li W, Kreisel D, Gelman AE, Lee JJ, Jacobsen EA, Krupnick AS.

JCI Insight. 2017 Dec 21;2(24). pii: 96455. doi: 10.1172/jci.insight.96455. [Epub ahead of print]


A systematic review and meta-analysis on the attribution of human papillomavirus (HPV) in neuroendocrine cancers of the cervix.

Castle PE, Pierz A, Stoler MH.

Gynecol Oncol. 2018 Feb;148(2):422-429. doi: 10.1016/j.ygyno.2017.12.001. Epub 2017 Dec 14. Review.


HPV E6/E7 mRNA In Situ Hybridization in the Diagnosis of Cervical Low-grade Squamous Intraepithelial Lesions (LSIL).

Mills AM, Coppock JD, Willis BC, Stoler MH.

Am J Surg Pathol. 2018 Feb;42(2):192-200. doi: 10.1097/PAS.0000000000000974.


In vivo lung perfusion rehabilitates sepsis-induced lung injury.

Mehaffey JH, Charles EJ, Schubert S, Salmon M, Sharma AK, Money D, Stoler MH, Laubach VE, Tribble CG, Roeser ME, Kron IL.

J Thorac Cardiovasc Surg. 2018 Jan;155(1):440-448.e2. doi: 10.1016/j.jtcvs.2017.08.124. Epub 2017 Sep 14.


Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial.

Huh WK, Joura EA, Giuliano AR, Iversen OE, de Andrade RP, Ault KA, Bartholomew D, Cestero RM, Fedrizzi EN, Hirschberg AL, Mayrand MH, Ruiz-Sternberg AM, Stapleton JT, Wiley DJ, Ferenczy A, Kurman R, Ronnett BM, Stoler MH, Cuzick J, Garland SM, Kjaer SK, Bautista OM, Haupt R, Moeller E, Ritter M, Roberts CC, Shields C, Luxembourg A.

Lancet. 2017 Nov 11;390(10108):2143-2159. doi: 10.1016/S0140-6736(17)31821-4. Epub 2017 Sep 5.


Test Characteristics of Specific p16 Clones in the Detection of High-grade Squamous Intraepithelial Lesions (HSIL).

Shain AF, Wilbur DC, Stoler MH, Quade BJ, Kong CS.

Int J Gynecol Pathol. 2018 Jan;37(1):82-87. doi: 10.1097/PGP.0000000000000391.


Mismatch repair status and PD-L1 expression in clear cell carcinomas of the ovary and endometrium.

Willis BC, Sloan EA, Atkins KA, Stoler MH, Mills AM.

Mod Pathol. 2017 Nov;30(11):1622-1632. doi: 10.1038/modpathol.2017.67. Epub 2017 Jul 28.


Lungs donated after circulatory death and prolonged warm ischemia are transplanted successfully after enhanced ex vivo lung perfusion using adenosine A2B receptor antagonism.

Charles EJ, Mehaffey JH, Sharma AK, Zhao Y, Stoler MH, Isbell JM, Lau CL, Tribble CG, Laubach VE, Kron IL.

J Thorac Cardiovasc Surg. 2017 Nov;154(5):1811-1820. doi: 10.1016/j.jtcvs.2017.02.072. Epub 2017 Apr 12.


Ex Vivo Lung Perfusion Rehabilitates Sepsis-Induced Lung Injury.

Mehaffey JH, Charles EJ, Sharma AK, Salmon M, Money D, Schubert S, Stoler MH, Tribble CG, Laubach VE, Roeser ME, Kron IL.

Ann Thorac Surg. 2017 Jun;103(6):1723-1729. doi: 10.1016/j.athoracsur.2017.01.018. Epub 2017 Apr 21.


Correction: Membrane associated cancer-oocyte neoantigen SAS1B/ovastacin is a candidate immunotherapeutic target for uterine tumors.

Pires ES, D'Souza RS, Needham MA, Herr AK, Jazaeri AA, Li H, Stoler MH, Anderson-Knapp KL, Thomas T, Mandal A, Gougeon A, Flickinger CJ, Bruns DE, Pollok BA, Herr JC.

Oncotarget. 2017 Feb 28;8(9):16099. doi: 10.18632/oncotarget.15755. No abstract available.

Supplemental Content

Loading ...
Support Center